Writing business

AIkido Pharma announces strategic investment in MasterClass

Masterclass gives members access to pre-recorded lectures by top experts

NEW YORK, April 5, 2022 /PRNewswire/ — AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that the Company has obtained an early stake in privately-held Yanka Industries, Inc., doing business as MasterClass (https://www.masterclass.com/). MasterClass describes itself as the “streaming platform where the world’s best come together so anyone, anywhere can access and be inspired by their knowledge and stories. With an annual subscription, members enjoy unprecedented access to over 150 instructors and courses across a wide variety of subject areas, including arts and entertainment, business, design and style, sports and games, writing and more.” (https://www.prnewswire.com/news-releases/masterclass-announces-professional-streamer-tyler-ninja-blevins-to-teach-how-to-become-a-streamer-in- 30-days-301497337.html).

In one December 21, 2021 article titled “30 startups we think could go public in 2022,” Crunchbase news said, “it wouldn’t be a big surprise to see San Francisco– MasterClass whose head office dips a toe into the public markets in the coming months. The online education platform offers courses on a wide range of topics and features well-known personalities including Malala Yousafzai, Spike LeeNeil of Grasse Tyson and Ringo Starr. It would have had a valuation of approximately $2.75 billion in May, more than triple in value over the course of a year.” (https://news.crunchbase.com/news/2022-startup-ipo-predictions-stripe-klarna-plaid-instacart-thrasio/).

Anthony HayesCEO of Aikido, said, “The extraordinary content provided by MasterClass truly lives up to its name. We are amazed by the wide range of topics and the number of prominent and renowned experts who have recorded the lectures provided by the MasterClass service. We are excited to be a part of this exceptional company, especially given the potential it offers to create value for our shareholders.As some market sectors begin to slow, we are constantly on the lookout for opportunities that will increase shareholder value.

In its press releases, MasterClass described itself as follows:

“ABOUT THE MASTER CLASS
“Created in 2015, Master class allows everyone to learn from the best. With MasterClass, enter Anna Wintour office, Timbaland recording studio, and by Neil Gaiman writing retreat. Improve your service with Serena Williamsperfect your pitch with Shonda Rhimes, and leave the mood with Chris Hadfield. Hundreds of video lessons from over 85 of today’s brightest minds are available anytime, anywhere on iOS, Android, desktop, Apple TV, Amazon Fire TV, Android TV and Roku devices with the All-Access Pass ($180/year). Subscribe to greatness with MasterClass.”

“The current list of MasterClass courses includes:

“Business: Howard Schultz (commercial management), Anna Wintour (creativity and leadership), Sara Blakely (self-taught entrepreneurship), Bob Iger (strategy and leadership), Chris Voss (art of negotiation), Goodby and Silverstein (advertising and creativity), Robin Robert (effective and authentic communication)

“Culinary Arts: Gordon Ramsay (kitchen), Alice Waters (cooking at home), Thomas Keller (culinary techniques), Wolfgang Puck (cooking), Dominique Ansel (French pastry), James Sucking (appreciation of wine), Aaron Franklin (Texan barbecue), Massimo Bottura (Italian cuisine), Gabriela Cámara (Mexican cuisine), Lynnette Marrero and Ryan Chetiyawardana (mixology)

“Cinema and television: Werner Herzog (filmmaking), Martin Scorsese (implementation), Ron Howard (direction), Spike Lee (implementation), Mira Nair (independent cinema), Jodie Foster (implementation), ken burns (production of documentary films), Helen Mirren (acting), Samuel L. Jackson (acting), Judd Apatow (the comedy), Aaron Sorkin (screenwriting), Shonda Rhimes (writing for television), Natalie Portman (acting), David Lynch (creativity and cinema)

“Way of life: Bobbi Brown (makeup and beauty), RuPaul (self-expression and authenticity), Kelly Wearstler (interior design), Ron Finley (gardening)

“Music and Entertainment: Steve Martin (comedy), Christina Aguilera (vocals), Usher (interpretation), Reba McEntire (country music), Herbie Hancock (jazz), Deadmau5 (music production), Armin Van Buuren (dance music), Hans Zimmer (movie soundtrack), Tom Morello (electric guitar), carlos santana (guitar art and soul), Timbaland (production and beatmaking), Penn & Teller (magic), Itzhak Perlman (violin), Danny Elfman (film score), Sheila E. (drums and percussion)

“In writing: James Patterson (writing), David Mamet (playwriting), Judy Blume (in writing), Malcolm Gladwell (writing), RL Stine (writing for young audiences), Margaret Atwood (creative writing), Dan Brown (writing thrillers), Neil Gaiman (story), Billy Collins (poetry), david baldaci (writing thrillers), Joyce Carol Oates (news writing), David Sedaris (tale and humor)

“Photography: Annie Leibovitz (photography), jimmy chin (adventure photography)

“Design and Fashion: Franck Gehry (architecture), Diana of Furstenberg (how to build a fashion brand), Marc Jacobs (fashion design)

“Sports and Games: Serena Williams (tennis) Stephen Curry (shooting, ball handling and goal), Garry Kasparov (chess), Daniel Negreanu (poker), Phil Ivey (poker strategy), Simone Biles (gymnastic), Foggy Copeland (ballet)

“Politics and society: Jane Goodall (conservation), Bob Woodward (investigative journalism), Karl Rove and David Axelrod (political campaign strategy), Paul Krugmann (economy and society), Doris KearnsGoodwin (US Presidential History and Leadership)

“Science and technology: Chris Hadfield (space exploration), Will Wright (game design), Neil deGrasse Tyson (scientific thinking and communication)

“For more information, please visit www.masterclass.com.”

(See, for example, https://www.prnewswire.com/news-releases/masterclass-raises-100-million-in-series-e-funding-301062884.html)

About AIkido Pharma Inc.

AIkido Pharma Inc. was originally established in 1967 and is a biotechnology company with a diverse portfolio of small molecule anticancer and antiviral therapeutics. The Company’s platform consists of patented technology sourced from leading universities and researchers, and we are currently developing an innovative therapeutic drug platform through strong partnerships with educational institutions. world-renowned, including the University of Texas in Austin and the University of Maryland at Baltimore. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer and prostate cancer. We are constantly looking to expand our pipeline to address unmet medical needs in oncology. The Company is also developing a broad-spectrum antiviral platform that could potentially inhibit the replication of several viruses, including influenza virus, SARS-CoV (coronavirus), MERS-CoV, Ebola virus and Marburg virus.

Forward-looking statements

Certain statements contained in this press release constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may”, “could”, “will”, “should”, “believe”, “expect”, “anticipate”, “estimate”, “continue”, “predict”, “plan” , “project”, “” Although the Company believes that these forward-looking statements are reasonable, undue reliance should not be placed on these forward-looking statements, which are based on information available to us as of the date of this release. These forward-looking statements are based on current estimates and assumptions and are subject to various risks and uncertainties, including, without limitation, those set forth in the Company’s filings with the SEC, without limitation to risk associated with its activities contained therein. Therefore, actual results could differ materially. The Company expressly disclaims any obligation to update or change any statements, whether as a result of new information, future events or otherwise, except as required by law.

Contact:

Investor Relations:

R.I. Hayden
Brett MaasManaging Partner
Telephone: (646) 536-7331
E-mail: [email protected]
www.haydenir.com

AIkido Pharma Inc.
Phone: 212-745-1373
E-mail: [email protected]
www.aikidopharma.com

SOURCEAIkido Pharma Inc.